| Primary |
| Chondrocalcinosis Pyrophosphate |
14.3% |
| Drug Use For Unknown Indication |
11.9% |
| Gout |
9.5% |
| Hypertension |
9.5% |
| Patent Ductus Arteriosus |
9.5% |
| Headache |
7.1% |
| Intracranial Pressure Increased |
4.8% |
| Osteoarthritis |
4.8% |
| Abdominal Pain |
2.4% |
| Analgesic Therapy |
2.4% |
| Back Pain |
2.4% |
| Blood Cholesterol Increased |
2.4% |
| Depression |
2.4% |
| Drug Exposure During Pregnancy |
2.4% |
| Hypothyroidism |
2.4% |
| Migraine With Aura |
2.4% |
| Musculoskeletal Pain |
2.4% |
| Nausea |
2.4% |
| Pain |
2.4% |
| Product Used For Unknown Indication |
2.4% |
|
| Small Intestinal Perforation |
10.0% |
| Weight Increased |
10.0% |
| Aggression |
5.0% |
| Cerebral Vasoconstriction |
5.0% |
| Gastritis Erosive |
5.0% |
| Myoclonus |
5.0% |
| Naevus Flammeus |
5.0% |
| Nephropathy |
5.0% |
| Pachymeningitis |
5.0% |
| Pleural Effusion |
5.0% |
| Sepsis Neonatal |
5.0% |
| Serotonin Syndrome |
5.0% |
| Shock |
5.0% |
| Spinal Cord Haemorrhage |
5.0% |
| Sudden Infant Death Syndrome |
5.0% |
| Tremor |
5.0% |
| Troponin Increased |
5.0% |
| Vertigo |
5.0% |
|
| Secondary |
| Congestive Cardiomyopathy |
11.1% |
| Product Used For Unknown Indication |
11.1% |
| Hypertension |
10.4% |
| Headache |
9.6% |
| Atrial Fibrillation |
5.2% |
| Gout |
5.2% |
| Bronchitis |
4.4% |
| Chondrocalcinosis Pyrophosphate |
4.4% |
| Drug Use For Unknown Indication |
4.4% |
| Fluid Retention |
4.4% |
| Intracranial Pressure Increased |
4.4% |
| Nasopharyngitis |
4.4% |
| Osteoarthritis |
4.4% |
| Hiv Infection |
3.0% |
| Abdominal Pain |
2.2% |
| Analgesic Therapy |
2.2% |
| Blood Cholesterol Increased |
2.2% |
| Hypothyroidism |
2.2% |
| Juvenile Arthritis |
2.2% |
| Nausea |
2.2% |
|
| Vomiting |
11.8% |
| Angioedema |
8.8% |
| Pachymeningitis |
8.8% |
| Pleural Effusion |
8.8% |
| Renal Failure Acute |
8.8% |
| Nasopharyngitis |
5.9% |
| Tinnitus |
5.9% |
| Weight Increased |
5.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.9% |
| Dyspraxia |
2.9% |
| Gastritis Erosive |
2.9% |
| Hepatic Function Abnormal |
2.9% |
| Hypoglycaemia |
2.9% |
| Leukopenia |
2.9% |
| Myoclonus |
2.9% |
| Nephropathy |
2.9% |
| Platelet Count Decreased |
2.9% |
| Pleurisy |
2.9% |
| Spinal Cord Haemorrhage |
2.9% |
| Tendon Pain |
2.9% |
|
| Concomitant |
| Rheumatoid Arthritis |
30.5% |
| Product Used For Unknown Indication |
28.1% |
| Pain |
5.5% |
| Prophylaxis |
5.5% |
| Hypertension |
4.3% |
| Multiple Myeloma |
2.6% |
| Constipation |
2.4% |
| Osteoporosis |
2.4% |
| Hyperuricaemia |
2.3% |
| Drug Use For Unknown Indication |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.9% |
| Ankylosing Spondylitis |
1.7% |
| Cardiac Failure Chronic |
1.7% |
| Pain Prophylaxis |
1.7% |
| Arthritis |
1.5% |
| Relapsing-remitting Multiple Sclerosis |
1.5% |
| Antibiotic Prophylaxis |
1.1% |
| Cancer Pain |
1.1% |
| Cardiac Failure |
1.1% |
| Depression |
1.1% |
|
| Hypertriglyceridaemia |
9.0% |
| Venoocclusive Disease |
7.5% |
| Vomiting |
7.5% |
| Herpes Zoster |
6.0% |
| Ovarian Haemorrhage |
6.0% |
| Paraplegia |
6.0% |
| Pyrexia |
6.0% |
| Uterine Leiomyoma |
6.0% |
| Asthma |
4.5% |
| Cellulitis |
4.5% |
| Diabetes Mellitus |
4.5% |
| General Physical Health Deterioration |
4.5% |
| Haemarthrosis |
4.5% |
| Intervertebral Disc Protrusion |
4.5% |
| Nausea |
4.5% |
| Death |
3.0% |
| Endometriosis |
3.0% |
| Metrorrhagia |
3.0% |
| Oedema Peripheral |
3.0% |
| Pain In Extremity |
3.0% |
|
